Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study.

RATIONALE Low blood levels of 25-hydroxyvitamin D (25[OH]D) have been associated with a higher risk of respiratory infections in general populations and higher risk of exacerbations of lung disease in people with asthma. We hypothesized that low blood levels of 25(OH)D in patients with chronic obstructive pulmonary disease (COPD) would be associated with an increased risk of acute exacerbations of COPD (AECOPD). OBJECTIVES To determine if baseline 25(OH)D levels relate to subsequent AECOPD in a cohort of patients at high risk for AECOPD. METHODS Plasma 25(OH)D was measured at baseline in 973 participants on entry to a 1-year study designed to determine if daily azithromycin decreased the incidence of AECOPD. Relationships between baseline 25(OH)D and AECOPD over 1 year were analyzed with time to first AECOPD as the primary outcome and exacerbation rate as the secondary outcome. MEASUREMENTS AND MAIN RESULTS In this largely white (85%) sample of North American patients with severe COPD (mean FEV(1) 1.12L; 40% of predicted), mean 25(OH)D was 25.7 ± 12.8 ng/ml. A total of 33.1% of participants were vitamin D insufficient (≥20 ng/ml but <30 ng/ml); 32% were vitamin D deficient (<20 ng/ml); and 8.4% had severe vitamin D deficiency (<10 ng/ml). Baseline 25(OH)D levels had no relationship to time to first AECOPD or AECOPD rates. CONCLUSIONS In patients with severe COPD, baseline 25(OH)D levels are not predictive of subsequent AECOPD. Clinical trial registered with www.clinicaltrials.gov (NCT00119860).

[1]  John Connett,et al.  Azithromycin for prevention of exacerbations of COPD. , 2011, The New England journal of medicine.

[2]  T. Rector,et al.  Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease , 2011, International journal of chronic obstructive pulmonary disease.

[3]  A. Auvinen,et al.  Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. , 2010, The Journal of infectious diseases.

[4]  R. Hoogenveen,et al.  Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach , 2010, European Respiratory Journal.

[5]  D. Niewoehner,et al.  Vitamin D status and longitudinal lung function decline in the Lung Health Study , 2010, European Respiratory Journal.

[6]  J. Brehm,et al.  Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. , 2010, The Journal of allergy and clinical immunology.

[7]  J. Hughes,et al.  Vitamin D and COPD: seasonal variation is important , 2010, Thorax.

[8]  P. DePetrillo,et al.  Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults , 2010, PloS one.

[9]  M. Urashima,et al.  Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. , 2010, The American journal of clinical nutrition.

[10]  M. Lehtinen,et al.  The Effects of Storage Time and Sampling Season on the Stability of Serum 25-Hydroxy Vitamin D and Androstenedione , 2009, Nutrition and cancer.

[11]  M. Decramer,et al.  Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene , 2009, Thorax.

[12]  J. Brehm,et al.  Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. , 2009, American journal of respiratory and critical care medicine.

[13]  B. Cunha,et al.  A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections , 2009, Epidemiology and Infection.

[14]  J. Maurer.  Predictors of Rehospitalization and Death After a Severe Exacerbation of COPD , 2009 .

[15]  C. Camargo,et al.  Vitamin D, respiratory infections, and asthma , 2009, Current allergy and asthma reports.

[16]  J A Anderson,et al.  Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited , 2008, European Respiratory Journal.

[17]  J. Bourbeau,et al.  Impact on patients’ health status following early identification of a COPD exacerbation , 2007, European Respiratory Journal.

[18]  Amir Sharafkhaneh,et al.  Risk indexes for exacerbations and hospitalizations due to COPD. , 2007, Chest.

[19]  S. Suissa.  Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[20]  J. Adams,et al.  Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response , 2006, Science.

[21]  H. Koeffler,et al.  Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  P. Jones.  St. George's Respiratory Questionnaire: MCID , 2005, COPD.

[23]  J. Menzin,et al.  Direct Costs of COPD in the U.S.: An Analysis of Medical Expenditure Panel Survey (MEPS) Data , 2005, COPD.

[24]  John H. White,et al.  Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression , 2004, The Journal of Immunology.

[25]  John H. White,et al.  Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression1 , 2004, The Journal of Immunology.

[26]  E. Rönmark,et al.  The costs of exacerbations in chronic obstructive pulmonary disease (COPD). , 2002, Respiratory medicine.

[27]  Harold Alan Pincus,et al.  The most expensive medical conditions in America. , 2002, Health affairs.

[28]  S. Sullivan,et al.  The costs of treating COPD in the United States. , 2001, Chest.

[29]  S. Sethi.  Infectious etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.

[30]  D. Kromhout,et al.  Stability of blood (pro)vitamins during four years of storage at −20 °C: Consequences for epidemiologic research , 1995 .

[31]  D. Kromhout,et al.  Stability of blood (pro)vitamins during four years of storage at -20 degrees C: consequences for epidemiologic research. , 1995, Journal of clinical epidemiology.

[32]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.